Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
NCT00339001 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2006-06-20
Summary
To evaluate the possibility that erythropoietin with early iron supplementation may induce retinopathy of prematurity or worsen this disease. In addition risk factors for the development of ROP will be checked.
Conditions
- Retinopathy of Prematurity
Interventions
- DRUG
-
erythropoietin and early iron supplements
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Principal Investigators
-
Jacob Kuint, MD · Sheba Medical Center
Eligibility
- Min Age
- 2 Weeks
- Max Age
- 3 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Completion
- 2006-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Long-term Ophthalmic Outcomes in Ex-premature Infants
NCT06649513 ·Status: NOT_YET_RECRUITING
-
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
NCT00589953 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
NCT03110341 ·Status: UNKNOWN ·Phase: PHASE3
-
Erythropoietin in HIE Neonate
NCT06590155 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial
NCT02564796 ·Status: TERMINATED ·Phase: PHASE2
-
Darbepoetin Administration to Preterm Infants
NCT00334737 ·Status: COMPLETED ·Phase: PHASE2
-
Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
NCT05806684 ·Status: UNKNOWN
-
Does Erythropoietin Improve Outcome in Very Preterm Infants?
NCT00413946 ·Status: COMPLETED ·Phase: PHASE2
-
Erythropoietin Treatment in Extremely Low Birth Weight Infants
NCT00593801 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity
NCT01079715 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations
NCT05880433 ·Status: COMPLETED
-
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
NCT05340465 ·Status: RECRUITING ·Phase: PHASE2
-
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
NCT00349726 ·Status: COMPLETED ·Phase: PHASE2
-
Inflammation and Cerebral Oxygenation in Preterm Newborns Following Fetal Red Blood Cell Transfusion Compared to Adult Red Blood Cell Transfusion
NCT06851390 ·Status: COMPLETED
-
Efficacy of Mydriatic Drops in Premature Infants
NCT03448640 ·Status: COMPLETED
-
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
NCT00513240 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Contribution of Acupuncture on Pain Related to the Screening of Premature Retinopathy (ROP) by Digital Camera
NCT03757871 ·Status: COMPLETED ·Phase: NA
-
Long Term Effects of Erythropoietin in Patients With Moderate to Severe Traumatic Brain Injury
NCT03061565 ·Status: COMPLETED
-
Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants
NCT01235923 ·Status: COMPLETED ·Phase: PHASE2
-
Erythropoietin in Premature Infants to Prevent Encephalopathy
NCT02550054 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Erythropoietin on Preterm Brain Injury
NCT02036073 ·Status: COMPLETED ·Phase: PHASE4
-
Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
NCT03163589 ·Status: UNKNOWN ·Phase: PHASE3
-
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
NCT01030575 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants
NCT01203514 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)
NCT00945789 ·Status: COMPLETED ·Phase: PHASE1/PHASE2